Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy

We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intr...

Full description

Bibliographic Details
Main Authors: Maria G. Kotoula, Fani Zacharaki, Evangelia E. Tsironi
Format: Article
Language:English
Published: Karger Publishers 2012-06-01
Series:Case Reports in Ophthalmology
Subjects:
Online Access:http://www.karger.com/Article/FullText/339656
_version_ 1828445269664989184
author Maria G. Kotoula
Fani Zacharaki
Evangelia E. Tsironi
author_facet Maria G. Kotoula
Fani Zacharaki
Evangelia E. Tsironi
author_sort Maria G. Kotoula
collection DOAJ
description We present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intravitreal injection of bevacizumab. To our knowledge, we report the first case of PDT-treated CSC complicated by severe visual loss. We can only speculate that the serous detachment of the posterior pole might have been caused by PDT-induced VEGF overexpression, explaining such an impressive response to Avastin treatment.
first_indexed 2024-12-10T21:55:52Z
format Article
id doaj.art-c62fdd88b92d485594dda8de3cf5794b
institution Directory Open Access Journal
issn 1663-2699
language English
last_indexed 2024-12-10T21:55:52Z
publishDate 2012-06-01
publisher Karger Publishers
record_format Article
series Case Reports in Ophthalmology
spelling doaj.art-c62fdd88b92d485594dda8de3cf5794b2022-12-22T01:32:03ZengKarger PublishersCase Reports in Ophthalmology1663-26992012-06-013219619910.1159/000339656339656Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous ChorioretinopathyMaria G. KotoulaFani ZacharakiEvangelia E. TsironiWe present a long followed up case of acute central serous chorioretinopathy (CSC) complicated by a severe visual loss due to massive pigment epithelium detachment of the macula after a full-dose photodynamic therapy (PDT). Rapid anatomical and functional improvement was observed after a single intravitreal injection of bevacizumab. To our knowledge, we report the first case of PDT-treated CSC complicated by severe visual loss. We can only speculate that the serous detachment of the posterior pole might have been caused by PDT-induced VEGF overexpression, explaining such an impressive response to Avastin treatment.http://www.karger.com/Article/FullText/339656BevacizumabCentral serous chorioretinopathyPhotodynamic therapy
spellingShingle Maria G. Kotoula
Fani Zacharaki
Evangelia E. Tsironi
Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
Case Reports in Ophthalmology
Bevacizumab
Central serous chorioretinopathy
Photodynamic therapy
title Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
title_full Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
title_fullStr Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
title_full_unstemmed Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
title_short Intravitreal Bevacizumab for Photodynamic Therapy-Induced Massive Macular Detachment in Acute Central Serous Chorioretinopathy
title_sort intravitreal bevacizumab for photodynamic therapy induced massive macular detachment in acute central serous chorioretinopathy
topic Bevacizumab
Central serous chorioretinopathy
Photodynamic therapy
url http://www.karger.com/Article/FullText/339656
work_keys_str_mv AT mariagkotoula intravitrealbevacizumabforphotodynamictherapyinducedmassivemaculardetachmentinacutecentralserouschorioretinopathy
AT fanizacharaki intravitrealbevacizumabforphotodynamictherapyinducedmassivemaculardetachmentinacutecentralserouschorioretinopathy
AT evangeliaetsironi intravitrealbevacizumabforphotodynamictherapyinducedmassivemaculardetachmentinacutecentralserouschorioretinopathy